If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,053.50    -6.00 (-0.57%)
Bid:
1,053.50
Ask:
1,054.50
Spread: 1.00 (0.095%)
Market Cap: £3.38b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

27 Mar 2023 15:44

RNS Number : 3560U
Persimmon PLC
27 March 2023
 

 

27 March 2023

Persimmon Plc (the "Company")

 

Director/PDMR Shareholding

 

Persimmon Plc announces that on 23 March 2023 and 27 March 2023 Jason Windsor, Chief Financial Officer, acquired 9,284 and 7,943 shares in the Company, respectively, in respect of the vesting of awards granted in July 2022 as compensation for share awards forfeited on leaving his previous employer. Also, on 23 March 2023 and 27 March 2023, Jason Windsor sold 4,371 and 3,740 shares in the Company, respectively, to settle the tax liability arising on the vesting of the awards and has retained the balance of the shares. 

 

The below notification, made in accordance with the requirements of article 19.3 of the UK Market Abuse Regulation, gives further details:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Jason Windsor

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Acquisition of shares following the vesting of an award granted in July 2022, as compensation for a 2020 deferred bonus share award forfeited by Jason Windsor on leaving his previous employer.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

9,284

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

23 March 2023

f)

Place of the transaction

 

Outside a trading venue

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10p each

 

 

 

GB0006825383

 

b)

 

Nature of the transaction

 

 

Sale of shares to settle tax liability on vesting of award in respect of the forfeited 2020 deferred bonus share award.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£12.26

4,371

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

23 March 2023

f)

Place of the transaction

 

London Stock Exchange (XLON); Main Market

Transaction 3

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Acquisition of shares following the vesting of an award granted in July 2022, as compensation for a 2021 deferred bonus share award forfeited by Jason Windsor on leaving his previous employer.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

7,943

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

27 March 2023

f)

Place of the transaction

 

Outside a trading venue

Transaction 4

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10p each

 

 

 

GB0006825383

 

b)

 

Nature of the transaction

 

 

Sale of shares to settle tax liability on vesting of award in respect of the forfeited 2021 deferred bonus share award.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£12.13

3,740

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

27 March 2023

f)

Place of the transaction

 

London Stock Exchange (XLON); Main Market

 

 

Tracy Davison

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALDXADNDEFA
Date   Source Headline
1st May 20252:20 pmRNSResult of AGM
1st May 20252:02 pmRNSTotal Voting Rights
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.